Ipsc Derived Progenitors

Herausgeber: Birbrair, Alexander

• Broschiertes Buch

Produktbeschreibung

iPSC Derived Progenitors, Volume Thirteen in the Advances in Stem Cell Biology series is a timely collection of information and new discoveries in the field of stem cell biology. The book addresses the importance of induced pluripotent stems cells and how can they be differentiated into different progenitors. Progenitors cells are often the first-step to making more differentiating cell types. This volume addresses iPSCs derived from bone, dental pulp, craniofacial, neural stem cells, otic, cardiac, and much more. The volume is written for researchers and scientists in stem cell therapy, cell biology, regenerative medicine, organ transplantation, and is contributed by world-renowned authors.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 318
• Erscheinungstermin: 12. November 2021
• Englisch
• Abmessung: 233mm x 195mm x 22mm
• Gewicht: 667g
• ISBN-13: 9780323855457
• ISBN-10: 0323855458
• Artikelnr.: 61567264

Inhaltsangabe

1. iPSC-derived Neural Stem Cells 2. iPSC-derived Craniofacial Mesenchymal
Progenitor Cells 3. Human induced pluripotent stem cell-derived astrocyte
progenitors as discovery platforms: opportunities and challenges 4. iPSCs
derived mesothelial progenitors; implications in cell-based regenerative
medicine 5. hiPSC-derived keratinocyte progenitors 6. Induced Pluripotent
Stem Cell Derived Bone Progenitors 7. Induced Pluripotent Stem
Cells-derived Chondrocyte Progenitors 8. iPSCs Derived Dental Pulp Stem
Cells: Future Application in Regenerative Medicine 9. Induced pluripotent
stem cell-derived nephron progenitors for kidney organoids 10. Interaction
of Mesenchymal Stromal Cells with the GI Tract and Microbiome in the
Management of Inflammatory Bowel Disease 11. iPSC-derived hematopoietic
progenitors for cellular immunotherapies 12. iPSCs as the Source of Cancer
Stem Cells Providing Novel Concepts of Cancer: Gaps between in vitro and in
vivo in iPSCs Modeling